[{"address1": "7800 Susquehanna St.", "address2": "Suite 505", "city": "Pittsburgh", "state": "PA", "zip": "15208", "country": "United States", "phone": "412 894 1853", "website": "https://www.lipella.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It is developing LP-10, a formulation of tacrolimus that is in Phase IIa clinical trial for patients with radiation-induced hemorrhagic cystitis; and LP-310, a formulation of tacrolimus for the treatment of oral lichen planus. Lipella Pharmaceuticals Inc. was incorporated in 2005 and is based in Pittsburgh, Pennsylvania.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jonathan  Kaufman M.B.A., Ph.D.", "age": 56, "title": "Co-Founder, Chairman, CEO, President, Secretary & Treasurer", "yearBorn": 1967, "fiscalYear": 2023, "totalPay": 204133, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael B. Chancellor M.D.", "age": 64, "title": "Co-Founder, Chief Medical Officer & Director", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 195833, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Douglas  Johnston CPA", "age": 38, "title": "Chief Financial Officer", "yearBorn": 1985, "fiscalYear": 2023, "totalPay": 185000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Michele  Gruber", "title": "Director of Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Katie  Johnston", "title": "Controller", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.7998, "open": 0.7503, "dayLow": 0.7412, "dayHigh": 0.7833, "regularMarketPreviousClose": 0.7998, "regularMarketOpen": 0.7503, "regularMarketDayLow": 0.7412, "regularMarketDayHigh": 0.7833, "volume": 33438, "regularMarketVolume": 33438, "averageVolume": 55908, "averageVolume10days": 67610, "averageDailyVolume10Day": 67610, "bid": 0.735, "ask": 0.8149, "bidSize": 100, "askSize": 100, "marketCap": 5455180, "fiftyTwoWeekLow": 0.64, "fiftyTwoWeekHigh": 2.71, "priceToSalesTrailing12Months": 12.132949, "fiftyDayAverage": 0.94058, "twoHundredDayAverage": 1.452715, "currency": "USD", "enterpriseValue": 1686007, "floatShares": 3768833, "sharesOutstanding": 7039850, "sharesShort": 31938, "sharesShortPriorMonth": 7651, "sharesShortPreviousMonthDate": 1706659200, "dateShortInterest": 1709164800, "sharesPercentSharesOut": 0.0050999997, "heldPercentInsiders": 0.45558998, "heldPercentInstitutions": 0.054819997, "shortRatio": 2.0, "shortPercentOfFloat": 0.0066000004, "impliedSharesOutstanding": 7039850, "bookValue": 0.519, "priceToBook": 1.4930637, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -4618965, "trailingEps": -0.77, "enterpriseToRevenue": 3.75, "enterpriseToEbitda": -0.355, "52WeekChange": -0.63095236, "SandP52WeekChange": 0.31995547, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "LIPO", "underlyingSymbol": "LIPO", "shortName": "Lipella Pharmaceuticals Inc.", "longName": "Lipella Pharmaceuticals Inc.", "firstTradeDateEpochUtc": 1671460200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "d39a1b66-6fea-3b6c-8773-cda09b9e9d93", "messageBoardId": "finmb_35907207", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.7749, "recommendationKey": "none", "totalCash": 3293738, "totalCashPerShare": 0.527, "ebitda": -4744268, "totalDebt": 136594, "quickRatio": 8.631, "currentRatio": 8.899, "totalRevenue": 449617, "debtToEquity": 4.344, "revenuePerShare": 0.075, "returnOnAssets": -0.62268, "returnOnEquity": -1.1813099, "freeCashflow": -1516392, "operatingCashflow": -3150172, "revenueGrowth": -0.2, "operatingMargins": -6.0375896, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-03-22"}]